5-Fluorouracil and leucovorin therapy in patients with hormone refractory prostate cancer: an Eastern Cooperative Oncology Group phase II study (E1889).

Berlin JD, Propert KJ, Trump D, Wilding G, Hudes G, Glick J, Burch P, Keller A, Loehrer P
Am J Clin Oncol. 1998 21 (2): 171-6

PMID: 9537206 · DOI:10.1097/00000421-199804000-00016

MeSH Terms (13)

Adenocarcinoma Aged Aged, 80 and over Antidotes Antimetabolites, Antineoplastic Fluorouracil Humans Leucovorin Male Middle Aged Neoplasms, Hormone-Dependent Prostatic Neoplasms Survival Analysis

Connections (1)

This publication is referenced by other Labnodes entities: